Circulating cardiac natriuretic peptide levels are being used increasingly in a range of
clinical circumstances. Since it is evident that drugs used in the treatment of cardiovascular …

The present study was designed to investigate the influence of exercise intensity and
duration as well as of inspiratory oxygen content on plasma atrial natriuretic peptide …

BACKGROUND Increased plasma concentrations of endothelin-1, a potent vasoconstrictor
produced by the endothelium, have been reported in various pathological conditions. This …

To study the mechanism of atrial natriuretic factor (ANF) release in heart failure, we
measured plasma ANF concentrations, cardiac volumes and filling pressures at rest and …

This study evaluates the release of atrial natriuretic factor (ANF) during maximal exercise in
7 patients with untreated moderate to severe hypertension with invasive monitoring of …

The role of atrial distension and/or adrenergic mechanisms in the regulation of atrial
natriuretic peptide (ANP) secretion, plasma immunoreactive ANP, norepinephrine (NE) …

Aims. We investigated whether levels of N-terminal proatrial natriuretic peptide (N-terminal
proANP) reflect the severity of coronary artery disease in chronic, stable angina pectoris …

The effects of single oral doses of dilevalol 400 mg and propranolol 80 mg on systemic and
regional haemodynamics at rest and after sub-maximal exercise, were compared, in a …

The effects of epanolol (200 mg once daily) and diltiazem (60 mg three times daily) on the
response of atrial natriuretic peptide (ANP) to exercise were investigated in a double-blind …

Octreotide inhibits the secretion of several hormones and exerts vasopressor effects. To
clarify the mechanism of atrial natriuretic factor (ANF) secretion and to assess the …